Sunday, May 4, 2025
Home Client Page 3

Client

    Latest

    GeoVax to Present at the 2024 BIO CEO & Investor Conference

    Client Editor / Curator -
    ATLANTA, GA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers...

    GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!

    Client Editor / Curator -
    Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants We were having cocktails at...

    GeoVax Labs (GOVX) JP Morgan 2024 Healthcare Conference Transcript.

    Client Editor / Curator -
    (Presentation text bolding for emphasis by Editors of the Biotech Stock Review, not the company.

    Revive Therapeutics (RVVTF) $0.02, Explores the Use of Bucillamine for Long COVID.

    Client Editor / Curator -
    Bucillamine is one of the most amazing drugs (in our opinion), which was repurposed from its original use as an anti-inflammatory for...

    Adding GeoVax (GOVX) $3.32 to Reverse Stock Split Watch List.

    Client Editor / Curator -
    Okay, Here's Our First Name for the Reverse Stock Split, Watch List. We'll Venture to Have 10 Names Added to Watch List...

    Research Report: Society Pass (SOPA) $0.22. Price Target $4.00.

    Client Editor / Curator -
    Three New Reports on Society Pass (SOPA) With Price Targets from $3.00 to $4.00. (All Report Archive)

    Is David Dodd on to his Next Billion Dollar Payday for Shareholders?

    Client Editor / Curator -
    Huge News: Gedeptin® Therapy Demonstrated Safety, Stabilization and Shrinkage of Treated Tumors. GeoVax (GOVX) Completes Patient...

    Citius Pharmaceuticals, Inc. (CTXR) Reports Fiscal Full Year 2023 Financial Results and Provides Business...

    Client Editor / Curator -
    Mino-Lok® Pivotal Phase 3 trial enrollment completed; topline data expected 2Q 2024 LYMPHIR™ BLA resubmission on track for early 2024

    Adding Geovax (GOVX) to 2024 Biotech Watch List.

    Client Editor / Curator -
    GEOVAX (GOVX) $0.32 We added this to the Watch List earlier in the...

    LQR House (LQR) Commits to Postpone Public Offerings for the Foreseeable Future.

    Beverage News Editor / Curator -
    LQR House Initiates Warrants Cancellation and Commits to Postpone Public Offerings for the Foreseeable Future
    1234...37Page 3 of 37

    Latest article

    Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

    All News Editor / Curator -
    Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

    Gold Price Sets New Intraday Record Above $3,500 (WSJ)

    All News Editor / Curator -
    Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...

    Gold Surges to a Record Above $3,400 as Trump threatens Fed Independence (CNBC)

    All News Editor / Curator -
    Gold prices broke $3,400 on Monday, hitting a new record as President Donald Trump’s threats against the...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.